Fundraising FoxNuFund Venture Group — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Cadenza Bio develops small-molecule drugs for oral administration to treat demyelinating and inflammatory diseases.
BiotechFemTechMedical DevicesYukon, US
Carol Curtis, PhD(Chief Executive Officer, Founder)Elaine Hamm, PhD(Chief Operating Officer, Founder)John Katzenellenbogen, PhD(Scientific Founder)Seema Tiwari-Woodruff, PhD(Scientific Founder)Elaine Hamm(Executive Officer, Director)Carol Curtis(Executive Officer, Director)in
Co-investorsCortado VenturesIllinois VenturesOklahoma Life SciencePlains VenturesSmartHealth Catalyzer
CARI Health develops diagnostic solutions for medication monitoring, specifically focused on personalized methadone dosing for opioid use disorder treatment.
BiotechDigital HealthHealthtechMedical DevicesSan Diego, US
Patrik Schmidle(Chief Executive Officer)
BoardGioia Messinger(Director)Charles Patton(Director)
Co-investorsCove FundDevice of Tomorrow Capital
PrivacyHawk is a consumer privacy company that helps individuals protect their personal data from spam, scams, identity theft, data selling, and hacking.
ConsumerCybersecuritySaaSLos Angeles, US
Aaron Mendes(Founder)inJustin Wright(Founder)in
Co-investorsAlumni VenturesCadron Capital PartnersFf Venture CapitalGaingelsK Street CapitalLalotte Ventures+5 more
__Twitter.png)
ROOK provides a wearable health data API that enables developers and companies to integrate health and fitness data from wearable devices into their applications.
Data & InfrastructureDigital HealthHealthtechIoTWellness & FitnessMiami, US
Marco Benitez(CEO)inDaniel Martinez(CTO)inJonas Dücker(CMO | COO)inOscar Garcia(CFO)inJose Esquivel(CQA)in
Co-investorsAllied Venture PartnersBreakaway Partners OÜHarvard Business Angels of ChicagoInsta VenturesLong Way VenturesPharmStars Ventures+6 more
Trio Pharmaceuticals develops dual-targeting antibody drugs to treat cancer, using its TIE-ADC and TRAILBody platforms to kill cancer cells and overcome tumor immunosuppression while reducing treatment-related toxicity.
BiotechHealthtechSan Diego, US
H. Kim Lyerly(CMO + Founder)inReiner Laus(Executive Officer, Director)Shivarupam Bhowmik(Executive Officer, Director)Jeffrey Friedman(Director)Patrick Doyle(CEO)inShiva Bhowmik, PhD(CSO + Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.